Cash, cash equivalents, and marketable securities of $360.1 million at Q3 2024 - CARLSBAD, Calif., Nov. 7, 2024 /PRNewswire/ -- Tyra Biosciences, Inc. (Nasdaq: TYRA), a clinical ...

The Bank of England on Thursday said it was cutting its key interest further after UK inflation hit a three-year low and ...

Delays in cargo clearance disrupt the flow of goods, increase costs, and undermine the country’s competitiveness in global trade. These delays impose substantial economic costs that adversely affect ...

Find insight on Domain, Sensata Technologies and more in the latest Market Talks covering Technology, Media and Telecom.

Chevron's strategic moves and positive developments position the company for growth and success, making it a strong choice ...

The FDA recently approved a phase 2 clinical trial to investigate the efficacy of leronlimab in patients with relapsed or ...

Khel Now is back with another analysis of the Indian football team players. Here's a look at the performances of players for National team!

With their innovative technology ASX medical imaging companies are capitalising on billions of dollars in contracts annually being awarded to companies by the US Department of Veterans Affairs.

Ameluz-photodynamic therapy in superficial basal cell carcinoma may improve the clearance of target lesions, as shown in ...

The FDA has lifted clinical holds on trials of zevor-cel, satri-cel, and CT071, and trials will now resume in the US.

Multiple players are exploring whether modalities designed to combat B cell malignancies can be repurposed against lupus, ...

Cipla share price had fallen after the company's September quarter results as analysts cut their target price, citing weaker than expected domestic business and challenges in its key products.